MedPath

Social Information Processing in Children: an ocUlo-pupillometric Tool for Standard Evaluation

Not Applicable
Recruiting
Conditions
Autism Spectrum Disorder
Interventions
Other: eye-tracker
Registration Number
NCT05596331
Lead Sponsor
University Hospital, Tours
Brief Summary

The goal of this observational study is to identify behavioral and physiological markers of social alterations in Autism Spectrum Disorders compared to Typically Developping peers. This single-centre study plan to use eye tracking to evaluate social disorders in Autism Spectrum Disorders (ASD). The investigators will estimate oculometric and pupillometric indices as potential ASD biomarkers. The study will last 4 years and will be organized in two phases.

Detailed Description

In a first phase (expected to last 12-16 months), after an experimental validation in typical adults, relevant oculometric and pupillometric indices will be identified in a typical population of children and in a clinically diagnosed population of ASD children.

In a second phase of the protocol (expected to last 32-36 months), biomarkers identified in the first phase will be tested on a larger population including other neurodevelopmental disorders.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
460
Inclusion Criteria

Phase 1

All groups have these 2 criteria in common:

Free, informed and signed consent of both parents Enrolment in the social security system

The other criteria per group are as follows:

Group of adult subjects without ASD : Age between 18 and 50 years Group of children without ASD

  • Age between 2 and 12 years
  • Group of children with ASD Age between 2 and 12 years Conformity with the diagnostic criteria of ASD according to DSM-V, ICD-10 or ICD-11

Phase 2

  • Group of children without TND : Age between 0 and 12 years
  • Group of children with TND, or whose diagnosis is in progress (via PCO referral) :

Age between 0 and 12 years Conformity to the diagnostic criteria of TND

Exclusion Criteria

Phase 1:

All groups have the 2 common exclusion criteria Known uncorrected visual pathologies Known personal neurological pathologies

And they have these criteria per group:

  • Group of adult subjects without ASD: Subject under guardianship or trusteeship Diagnosis of ASD Group of children without ASD : Diagnosis of ASD
  • Group of children with ASD ICD-10 diagnosis of PDD (Rett syndrome and Hayler syndrome) Phase 2
  • Group of children without ASD : Diagnosis of ASD (confirmed or ongoing)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group of children without NDD (NeuroDevelopmental Disorders)eye-trackerAge between 0 and 12 years
Group of adult subjects without ASD (Autism Spectrum Disorders)eye-trackerAge between 18 and 50 years
Group of children with NDD, or whose diagnosis is in progresseye-trackerConformity to the diagnostic criteria of NDD
Group of children with ASDeye-trackerAge between 2 and 12 years Conformity with the diagnostic criteria of ASD according to DSM-V, ICD-10 or ICD-11
Group of children without ASDeye-trackerAge between 2 and 12 years
Primary Outcome Measures
NameTimeMethod
Oculometric measurements 1: Tracking timethrough study completion, an average of 1 year (first phase) and of 2 years (second phase)

Mean of tracking time (ms) during entire stimuli duration

Oculometric measurements 3: Fixation time on the eye area during entire stimuli durationthrough study completion, an average of 1 year (first phase) and of 2 years (second phase)

Mean of fixation time on the eye area of face stimuli (ms) during entire stimuli duration

Oculometric measurements 2: Fixation time on the screenthrough study completion, an average of 1 year (first phase) and of 2 years (second phase)

Mean of fixation time on the screen (ms) during entire stimuli duration

Discriminative powerthrough study completion, an average of 1 year (first phase) and of 2 years (second phase)

AUROC (Area Under the Receiver Operating Characteristics, in percent) analysis of combined oculometric and pupillometric measurements. Scale score : 0-100% (above 70% : good performance; above 80% : excellent performance; above 90% : outstanding performance)

Oculometric measurements 4: Fixation time on the mouth area of face stimulithrough study completion, an average of 1 year (first phase) and of 2 years (second phase)

Mean of fixation time on the mouth area of face stimuli (ms) during entire stimuli duration

Pupillometric measurementsthrough study completion, an average of 1 year (first phase) and of 2 years (second phase)

Mean of pupil dilation variation(mm) in response to entire stimuli duration

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Service de Pédopsychiatrie-CHU-TOURS

🇫🇷

Tours, France

© Copyright 2025. All Rights Reserved by MedPath